You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 7, July 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hyperthyroidism Caused by Inappropriate Thyrotropin Hypersecretion

Studies in Patients With Selective Pituitary Resistance to Thyroid Hormone

Robert G. Spanheimer, MD; Robert S. Bar, MD; John C. Hayford, MD

Arch Intern Med. 1982;142(7):1283-1286.


Abstract



• We have identified the condition of thyrotropin (thyroid-stimulating hormone [TSH])-induced hyperthyroidism secondary to selective pituitary insensitivity to thyroid hormone in three patients. Each patient was clinically hyperthyroid, with elevated serum levels of thyroxine (T4) and triiodothyronine (T3) and detectable levels of serum TSH before therapy. After therapy, each patient had notably elevated TSH levels at a time that peripheral levels of thyroid hormones were in the hyperthyroid range. Before and after therapy, serum levels of TSH were suppressed by therapy with liothyronine sodium and were stimulated by protirelin (thyrotropin-releasing hormone) both before and after liothyronine and dexamethasone treatment. Dexamethasone therapy decreased the levels of TSH, protirelin-stimulated TSH, and circulating T4 and T3. Serum levels of glycoprotein {alpha}-subunit were 0.6 to 2.4 ng/ml, values considerably lower than found in patients with TSH-secreting pituitary tumors. We suggest that the frequency of TSH-induced hyperthyroidism secondary to pituitary insensitivity to thyroid hormone may be higher than presently indicated in the medical literature.

(Arch Intern Med 1982;142:1283-1286)



Author Affiliations



From the Departments of Internal Medicine (Drs Spanheimer and Bar) and Pediatrics (Dr Hayford), Veterans Administration Hospital, University of Iowa, Iowa City.


Footnotes



Accepted for publication March 17, 1982.

Reprint requests to VA Hospital, 3E-21, University of Iowa, Iowa City, IA 52240 (Dr Bar).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prenatal Diagnosis of Thyroid Hormone Resistance
Asteria et al.
J. Clin. Endocrinol. Metab. 1999;84:405-410.
ABSTRACT | FULL TEXT  

Identification of a thyroid hormone receptor that is pituitary-specific
Hodin et al.
Science 1989;244:76-79.
ABSTRACT  

Hyperthyroidism due to Thyrotropin-Secreting Pituitary Tumors: Diagnostic and Therapeutic Considerations
Smallridge and Smith
Arch Intern Med 1983;143:503-507.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.